Fierce Healthcare May 6, 2022
Tech company Tempus has notched a partnership with the Department of Veterans Affairs (VA) to provide patients with cancer access to cutting-edge genetic testing to improve treatment.
There are 9 million veterans served by the VA health system. It’s estimated there are approximately 40,000 new cancer cases in veterans reported annually. And as the veteran population continues to age, this number will continue to rise.
Through a multiyear agreement, the VA’s National Precision Oncology Program will have access to Tempus’ portfolio of next-generation sequencing offerings to support...